Images

Filter by

Table 1 Anti hyperkalaemia Treatment Potassium Scavengers
Table 1: Anti-hyperkalaemia Treatment: Potassium Scavengers
Figure 2 Flow Chart for the Management of Hyperkalaemia of Cardiorenal Origin Non urgent Chronic Management29 30 32–36
Figure 2: Flow Chart for the Management of Hyperkalaemia of Cardiorenal Origin (Non-urgent [Chronic] Management)29,30,32–36
Figure 1 Flow Chart for the Management of Hyperkalaemia of Cardiorenal Origin Urgent Acute Management29 30 32–36
Figure 1: Flow Chart for the Management of Hyperkalaemia of Cardiorenal Origin (Urgent [Acute] Management)29,30,32–36
Box 2 Nutritional Recommendations to Reduce the Risk of Hyperkalaemia29–31
Box 2: Nutritional Recommendations to Reduce the Risk of Hyperkalaemia29–31
Box 1 Risk Factors for Developing Hyperkalaemia3 4
Box 1: Risk Factors for Developing Hyperkalaemia3,4
Table 5 Model Coefficients Number of Heart Failure Hospitalisations Emergency Department Visits During Follow up
Table 5: Model Coefficients: Number of Heart Failure Hospitalisations/ Emergency Department Visits During Follow-up
Table 4 Factors Associated with Heart Failure Hospitalisations Emergency Department Visits During Follow up Fit of Regression Models
Table 4: Factors Associated with Heart Failure Hospitalisations/Emergency Department Visits During Follow-up: Fit of Regression Models
Table 3 Events Adverse Effects and Uptitration of Vericiguat During Follow Up
Table 3: Events, Adverse Effects and Uptitration of Vericiguat During Follow-Up
Figure 2 Evolution of Systolic Blood Pressure N terminal Pro B type Natriuretic Peptide and Mean Number of Heart Failure Hospitalisations Emergency Department Visits after Initiation of Treatment with Vericiguat
Figure 2: Evolution of Systolic Blood Pressure, N-terminal Pro-B-type Natriuretic Peptide and Mean Number of Heart Failure Hospitalisations/Emergency Department Visits after Initiation of Treatment with Vericiguat
Figure 1 Evolution of New York Heart Association Functional Class after Initiation of Treatment with Vericiguat
Figure 1: Evolution of New York Heart Association Functional Class after Initiation of Treatment with Vericiguat
Table 2 Evolution of Heart Failure Treatments
Table 2: Evolution of Heart Failure Treatments
Table 1 cont
Table 1 (cont)